Your browser doesn't support javascript.
loading
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
Kong, Fan-En; Tang, Yun-Qiang; Gong, Yuan-Feng; Mo, Jia-Qiang; Zhao, Yue; Li, Mei-Mei; Cheng, Wei; Li, Hao-Long; Zhu, Wen-Jie; Liu, Shan-Shan; Huang, Li; Guan, Xin-Yuan; Ma, Ning-Fang; Liu, Ming.
Affiliation
  • Kong FE; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Tang YQ; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Gong YF; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Mo JQ; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Zhao Y; Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Li MM; General, Visceral and Cancer Surgery, University Hospital of Cologne, Cologne, Germany.
  • Cheng W; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Li HL; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Zhu WJ; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Liu SS; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Huang L; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Guan XY; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Ma NF; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Liu M; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
Hepatol Int ; 14(4): 521-533, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32304089
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Hepatocytes / Claudins / Liver Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Hepatol Int Year: 2020 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Hepatocytes / Claudins / Liver Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Hepatol Int Year: 2020 Type: Article Affiliation country: China